BioMarin Pharmaceutical
NASDAQ: BMRN
$81.76
+$2.25 (+2.8%)
Real time price as of March 30, 2020 1:14 pm EDT
Tuesday's top analyst calls included Advanced Micro Devices, Alcoa, Biomarin Pharmaceutical, Coca-Cola, Ford, General Motors, Intel, Kinder Morgan, Micron Technology, Nvidia, Tesla, Twitter and...
6 days ago
Last Updated: 6 days ago
24/7 Wall St. has put together a preview of AbbVie, American Airlines, Netflix, Starbucks and some of the other most prominent earnings reports due in this truncated trading week.
2 months ago
Last Updated: 2 months ago
These five top stocks spread across different sectors offer tremendous upside to the Goldman Sachs price objectives.
2 months ago
Last Updated: 2 months ago
Tuesday's top analyst upgrades, downgrades and initiations included Albermarle, Amgen, Applied Materials, Biogen, CRISPR Therapeutics, CrowdStrike, CSX, Kroger, Slack, Teva Pharmaceutical and Xerox.
4 months ago
Last Updated: 1 month ago
Wednesday's top analyst upgrades, downgrades and initiations included Advanced Micro Devices, Apple, Biomarin, Corning, Electronic Arts, FireEye, Grubhub, Nordstrom, NXP Semiconductors, Shopify and...
5 months ago
Last Updated: 1 month ago
Credit Suisse and Merrill Lynch made calls in the biotech and pharmaceutical space last week, ahead of coming earnings reports.
5 months ago
Last Updated: 1 month ago
Thursday's top analyst upgrades, downgrades and initiations included Abbott Laboratories, CSX, IBM, Netflix, Occidental Petroleum, Whiting Petroleum, Amgen, Gilead Sciences, Merck and Pfizer.
5 months ago
Last Updated: 1 month ago
The top analyst upgrades, downgrades and initiations on Wednesday included Acacia Communications, Baidu, BioMarin Pharmaceuticals, Boeing, BP, CSX, Deere, HCA, PepsiCo, Redfin, S&P Global,...
8 months ago
Last Updated: 1 month ago
With the three major stock indexes trading at or near all-time highs, many investors are scratching their heads about where to look for new investment ideas at a time when interest rates have become...
8 months ago
Last Updated: 1 month ago
Despite the wearing down of hepatitis C drugs and the political climate targeting drug prices, this analyst sees stabilization and predictability in the base businesses of two key biotech leaders.
10 months ago
Last Updated: 1 month ago
Shares of these five top companies offer tremendous upside to the Goldman Sachs price objective. While there is no guarantee they get there, moving just halfway to the targets would be outsized gains...
1 year ago
Last Updated: 1 month ago
These five top stocks across five sectors offer tremendous upside to the Goldman Sachs price objectives. Moving just halfway to the targets would be outsized gains for investors.
1 year ago
Last Updated: 16 days ago
The biotech team at SunTrust feel that it would not be a major surprise to see these six top companies post quarterly results that beat top-line Wall Street expectations.
1 year ago
Last Updated: 1 month ago
The top analyst upgrades, downgrades and initiations seen on Wednesday included Aflac, Akamai, BioMarin, Caesars Entertainment, CBS, Crocs, GW Pharma, Medtronic, Netflix and Sirius XM.
1 year ago
Last Updated: 1 month ago
The top analyst upgrades, downgrades and initiations seen on Friday included Activision Blizzard, BioMarin Pharmaceuticals, Ciena, Delta Air Lines, GlaxoSmithKline, Procter & Gamble, Regeneron...
1 year ago
Last Updated: 2 months ago